Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Kandzari, MD
Piedmont Heart Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cardiology Associates of Mobile
Fairhope, Alabama, United States
- John Muir Medical Center
Concord, California, United States
- St. Joseph Hospital Orange
Orange, California, United States
- Medstar Washington Hospital Center
Washington D.C., District of Columbia, United States
- Adventhealth Tampa
Tampa, Florida, United States
- Piedmont Heart Institute
Atlanta, Georgia, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- Advocate Lutheran General Hospital
Park Ridge, Illinois, United States
- Ascension St. Vincent Medical Group
Indianapolis, Indiana, United States
- Ascension Via Christi Hospitals
Wichita, Kansas, United States
- University of Kentucky
Lexington, Kentucky, United States
- Northern Light Cardiology
Bangor, Maine, United States
- Medstar Union Memorial Hospital
Baltimore, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Baystate Medical Center
Springfield, Massachusetts, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- Minneapolis Heart Institute
Minneapolis, Minnesota, United States
- Saint Michael'S Medical Center
Newark, New Jersey, United States
- Maimonides Medical Center
Brooklyn, New York, United States
- Columbia University Medical Center
New York, New York, United States
- Weill Cornell Medical College
New York, New York, United States
- Mercy Health - St Vincent Medical Center
Toledo, Ohio, United States
- Penn State Health Holy Spirit Medical Center
Camp Hill, Pennsylvania, United States
- Anmed Health
Anderson, South Carolina, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Austin Heart
Austin, Texas, United States
- Seton Medical Center Austin
Austin, Texas, United States
- Baylor Heart and Vascular Hospital
Dallas, Texas, United States
- Ut Health Science Center
Houston, Texas, United States
- University of Virginia Health System
Charlottesville, Virginia, United States
- Charleston Area Medical Center Memorial Hospital
Charleston, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Jan 2020
- Primary completion
- 12 Jan 2022
- Completion
- 8 Jan 2026
- Last update posted
- 27 Feb 2026
- Registered enrollment
- 556
- Registry id
- NCT04175626
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.